Speaker : Sylvain Berthelot
Session: Will direct-to-patient shipment shift from emergency solution to routine practice?
- Reflect on how it was applied as a response to the pandemic
- Highlight the risks of DtP and how they can be mitigated
- Discuss how to approach a direct-to-patient strategy
- Consider how the process can be improved in the future
When: Tuesday (Day 1) @ 12:30 CET- Clinical Technology Stream
Speakers
Sylvain Berthelot
Director, Solution Consultant, Calyx
Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.
